Top compounds associated with response to CCDC102A


Feature Type Standardized
Nominal ANOVA
mRNA Elesclomol GDSC1000 pan-cancer AAC 0.19 1e-08
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.17 1e-06
mRNA TW 37 GDSC1000 pan-cancer AAC 0.16 1e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 8e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA AUY922 GDSC1000 pan-cancer AAC 0.15 3e-05
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.13 3e-05
Download CSV